Article 13 Oct 2025 The Telehealth Cliff Has Arrived: What's Changing And What To Watch United States Healthcare
Article 28 Jul 2025 Inside The Ninth Circuit's Interpretation Of EKRA: Clarity For Kickback Law United States Healthcare
Article 18 Mar 2025 Proving Fraud Is And Should Be Hard: Lessons From A Recent Medicare Advantage False Claims Act Decision United States Healthcare
Article 27 Dec 2024 Congress Extends Telehealth Flexibilities For Two More Years United States Healthcare
Article 17 Dec 2024 Special Fraud Alert: Suspect Payments In Marketing Arrangements Related To Medicare Advantage And Providers United States Healthcare
Article 10 Sep 2024 Key Telehealth Updates In The CY 2025 Physician Fee Schedule Proposed Rule United States Healthcare
Article 14 May 2024 Increased Scrutiny Into Agents & Brokers In The Medicare Advantage Space United States Healthcare
Article 18 Oct 2023 OIG Confirms The Broad Protection Of Employee Safe Harbor United States Healthcare
Article 23 Aug 2022 OIG Blesses Gift Cards For Patient Engagement With Education Tool United States Healthcare
Article 04 Jul 2022 Supreme Court Decision In Dobbs v. Jackson Women's Health Organization Overturns 50 Years Of Precedent On Abortion Laws And Rights United States Healthcare
Article 30 Jun 2022 California District Court Finds That EKRA Applies To Compensation Methodologies For Labs' Employed Marketers Who Market To Physicians United States Healthcare
Article 21 Jun 2022 Supreme Court Saves Hospitals From $1.6B Cut To 340B Program United States Healthcare
Article 07 Feb 2022 Top 5 Legal Issues In Digital Health To Watch For In 2022 United States Healthcare
Article 15 Dec 2021 Debate Continues Around Scope Of Practice Expansion For APPs United States Healthcare
Article 13 Aug 2021 Physician Group Practices Take Heed – January 1, 2022 Deadline Approaches For Compliance With CMS' Recent Changes To Permissible "Group Practice" Compensation Methodologies United States Healthcare
Article 06 Jul 2021 340B Drug Pricing Discount Program Update: HRSA Now Demands That Drug Manufacturers Provide 340B Discounts To Contract Pharmacies Amid Ongoing Litigation United States Healthcare